5
Orphan Designations
0
FDA Approvals
5
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| T-cell non-Hodgkin lymphoma | nanatinostat and valganciclovir | Orphan Designation | - |
| angioimmunoblastic T-cell lymphoma | nanatinostat and valganciclovir | Orphan Designation | - |
| nasopharyngeal carcinoma | Nanatinostat and valganciclovir combination | Orphan Designation | - |
| plasmablastic lymphoma | nanatinostat and valganciclovir | Orphan Designation | - |
| post-transplant lymphoproliferative disease | nanatinostat and valganciclovir | Orphan Designation | - |